The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post Q&A: Should you trust trending peptide injections? BPC 157 Banned: Key Facts on the Latest FDA Decision